Annual EBIT
-$11.32 M
+$6.04 M+34.78%
December 31, 2023
Summary
- As of February 7, 2025, ALLR annual earnings before interest & taxes is -$11.32 million, with the most recent change of +$6.04 million (+34.78%) on December 31, 2023.
- During the last 3 years, ALLR annual EBIT has fallen by -$5.22 million (-85.60%).
- ALLR annual EBIT is now -85.60% below its all-time high of -$6.10 million, reached on December 31, 2020.
Performance
ALLR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$11.92 M
-$10.71 M-890.61%
September 1, 2024
Summary
- As of February 7, 2025, ALLR quarterly earnings before interest & taxes is -$11.92 million, with the most recent change of -$10.71 million (-890.61%) on September 1, 2024.
- Over the past year, ALLR quarterly EBIT has dropped by -$8.17 million (-218.21%).
- ALLR quarterly EBIT is now -890.61% below its all-time high of -$1.20 million, reached on June 1, 2024.
Performance
ALLR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$18.27 M
-$7.50 M-69.68%
September 1, 2024
Summary
- As of February 7, 2025, ALLR TTM earnings before interest & taxes is -$18.27 million, with the most recent change of -$7.50 million (-69.68%) on September 1, 2024.
- Over the past year, ALLR TTM EBIT has dropped by -$6.47 million (-54.80%).
- ALLR TTM EBIT is now -1183.29% below its all-time high of -$1.42 million, reached on September 30, 2020.
Performance
ALLR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ALLR EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +34.8% | -218.2% | -54.8% |
| 3 y3 years | -85.6% | -218.2% | -54.8% |
| 5 y5 years | +27.7% | -218.2% | -54.8% |
ALLR EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +56.3% | -890.6% | +27.3% | -69.7% | +40.5% |
| 5 y | 5-year | -85.6% | +56.3% | -890.6% | +27.3% | -1183.3% | +40.5% |
| alltime | all time | -85.6% | +56.3% | -890.6% | +27.3% | -1183.3% | +40.5% |
Allarity Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$11.92 M(+890.6%) | -$18.27 M(+69.7%) |
| Jun 2024 | - | -$1.20 M(-67.9%) | -$10.77 M(-8.8%) |
| Mar 2024 | - | -$3.75 M(+165.8%) | -$11.80 M(+4.3%) |
| Dec 2023 | -$11.32 M(-34.8%) | -$1.41 M(-68.1%) | -$11.32 M(-12.5%) |
| Sep 2023 | - | -$4.41 M(+97.2%) | -$12.94 M(-4.3%) |
| Jun 2023 | - | -$2.24 M(-31.3%) | -$13.52 M(-17.3%) |
| Mar 2023 | - | -$3.26 M(+7.8%) | -$16.35 M(-5.8%) |
| Dec 2022 | -$17.36 M | -$3.02 M(-39.5%) | -$17.36 M(-43.5%) |
| Sep 2022 | - | -$5.00 M(-1.4%) | -$30.71 M(+13.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$5.07 M(+18.7%) | -$27.00 M(-0.5%) |
| Mar 2022 | - | -$4.27 M(-73.9%) | -$27.14 M(+5.0%) |
| Dec 2021 | -$25.88 M(+324.2%) | -$16.38 M(+1170.8%) | -$25.84 M(+136.2%) |
| Sep 2021 | - | -$1.29 M(-75.2%) | -$10.94 M(-1.2%) |
| Jun 2021 | - | -$5.20 M(+74.9%) | -$11.07 M(+88.5%) |
| Mar 2021 | - | -$2.97 M(+101.2%) | -$5.88 M(+102.4%) |
| Dec 2020 | -$6.10 M(-61.1%) | -$1.48 M(+3.8%) | -$2.90 M(+103.8%) |
| Sep 2020 | - | -$1.42 M | -$1.42 M |
| Dec 2019 | -$15.66 M | - | - |
FAQ
- What is Allarity Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Allarity Therapeutics?
- What is Allarity Therapeutics annual EBIT year-on-year change?
- What is Allarity Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Allarity Therapeutics?
- What is Allarity Therapeutics quarterly EBIT year-on-year change?
- What is Allarity Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Allarity Therapeutics?
- What is Allarity Therapeutics TTM EBIT year-on-year change?
What is Allarity Therapeutics annual earnings before interest & taxes?
The current annual EBIT of ALLR is -$11.32 M
What is the all time high annual EBIT for Allarity Therapeutics?
Allarity Therapeutics all-time high annual earnings before interest & taxes is -$6.10 M
What is Allarity Therapeutics annual EBIT year-on-year change?
Over the past year, ALLR annual earnings before interest & taxes has changed by +$6.04 M (+34.78%)
What is Allarity Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of ALLR is -$11.92 M
What is the all time high quarterly EBIT for Allarity Therapeutics?
Allarity Therapeutics all-time high quarterly earnings before interest & taxes is -$1.20 M
What is Allarity Therapeutics quarterly EBIT year-on-year change?
Over the past year, ALLR quarterly earnings before interest & taxes has changed by -$8.17 M (-218.21%)
What is Allarity Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of ALLR is -$18.27 M
What is the all time high TTM EBIT for Allarity Therapeutics?
Allarity Therapeutics all-time high TTM earnings before interest & taxes is -$1.42 M
What is Allarity Therapeutics TTM EBIT year-on-year change?
Over the past year, ALLR TTM earnings before interest & taxes has changed by -$6.47 M (-54.80%)